| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |